Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFirst and only non-adjuvanted feline leukemia virus (FeLV) vaccine built on RNA particle technology
LEARN MOREFirst and only canine flu vaccine built on RNA particle technology
LEARN MOREFor the vaccination of healthy 18-day old chicken embryos or chickens 1-day of age against standard and variant infectious bursal disease.
LEARN MORE